In contrast, in ICC cells, activation of β-catenin with SKL-2001 resulted in significantly reduced expression of β-catenin, CCND1, N-cadherin, and vimentin after treatment with bufalin (Fig. 4E, F). This evidence concerns the gene CDH2 and intrahepatic cholangiocarcinoma.